OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
- 1 September 1995
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (1) , 2-7
- https://doi.org/10.1111/j.1365-2141.1995.tb05236.x
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- CYTOTOXIC T LYMPHOCYTE PRECURSOR FREQUENCY ANALYSES IN BONE MARROW TRANSPLANTATION WITH VOLUNTEER UNRELATED DONORS VALUE IN DONOR SELECTIONTransplantation, 1995
- Management of chronic myeloid leukaemiaBlood Reviews, 1994
- Autografting for patients with CML in chronic phase: an updateBritish Journal of Haematology, 1994
- CAMPATH-1 Monoclonal Antibodies in Bone Marrow TransplantationJournal of Hematotherapy, 1994
- Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTYBritish Journal of Haematology, 1991
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemiaNature, 1987
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Involvement of the B-lymphoid system in chronic myelogenous leukaemiaNature, 1980
- KARYOTYPIC CONVERSION IN Ph1-POSITIVE CHRONIC MYELOID LEUKÆMIA WITH COMBINATION CHEMOTHERAPYThe Lancet, 1979